Minerva Neurosciences (NERV) Return on Capital Employed Growth (1y) (2015 - 2026)
Minerva Neurosciences (NERV) Return on Capital Employed Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,132.22 Bn | 67,131.94 Bn | - | 1,648.00 |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - | - |
| 3 | Akari Therapeutics | 973.81 Bn | 973.81 Bn | - | 31,429.00 |
| 4 | BeOne Medicines | 471.45 Bn | 466.66 Bn | 1.35 Bn | 1,805.00 |
| 5 | Vertex Pharmaceuticals | 122.00 Bn | 114.75 Bn | 2.59 Bn | 2,503.00 |
| 6 | Regeneron Pharmaceuticals | 69.99 Bn | 61.23 Bn | 3.31 Bn | -105.00 |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - | - |
| 8 | Argenx Se | 55.86 Bn | 50.67 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.46 Bn | 959.66 Mn | 2,400.00 |
| 10 | Minerva Neurosciences | 183.94 Mn | 183.94 Mn | - | 2,729.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,729.00 |
| Dec 31, 2025 | 3,396.00 |
| Sep 30, 2025 | 606.00 |
| Jun 30, 2025 | 371.00 |
| Mar 31, 2025 | -968.00 |
| Dec 31, 2024 | -1,803.00 |
| Sep 30, 2024 | -2,712.00 |
| Jun 30, 2024 | -2,424.00 |
| Mar 31, 2024 | -363.00 |
| Dec 31, 2023 | 423.00 |
| Sep 30, 2023 | 3,503.00 |
| Jun 30, 2023 | 3,305.00 |
| Mar 31, 2023 | 2,048.00 |
| Dec 31, 2022 | 865.00 |
| Sep 30, 2022 | -3,724.00 |
| Jun 30, 2022 | -3,752.00 |
| Mar 31, 2022 | -7,304.00 |
| Dec 31, 2021 | -5,684.00 |
| Sep 30, 2021 | 670.00 |
| Jun 30, 2021 | 1,837.00 |